ECORElectroCore Inc
ECOR
ElectroCore Inc9,115
Mkt Cap
$52.01MVolume
182,555.0052W High
$8.6452W Low
$4.16PE Ratio
-3.46ECOR Fundamentals
Price
$6.27Prev Close
$6.43Open
$6.2750D MA
$6.42Beta
1.02Avg. Volume
68,061.63EPS (Annual)
-$1.65P/B
-8.96Rev/Employee
$385,927.71$35.84
electroCore Q1 Earnings Call Highlights
electroCore (NASDAQ:ECOR) executives highlighted record quarterly revenue, expanding margins, and continued progress toward profitability during the company's first-quarter 2026 earnings call, while also discussing a leadership transition and commercial priorities across federal and consumer channel...
MarketBeat·11d ago
electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates
electroCore (ECOR) delivered earnings and revenue surprises of -0.86% and +7.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11d ago
Insider Selling: electroCore (NASDAQ:ECOR) Director Sells 16,072 Shares of Stock
electroCore, Inc. (NASDAQ:ECOR - Get Free Report) Director Daniel Goldberger sold 16,072 shares of electroCore stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $6.02, for a total value of $96,753.44. Following the sale, the director directly owned 291,471...
MarketBeat·1mo ago
electroCore (NASDAQ:ECOR) Director Daniel Goldberger Sells 16,072 Shares
electroCore, Inc. (NASDAQ:ECOR - Get Free Report) Director Daniel Goldberger sold 16,072 shares of the firm's stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $6.02, for a total transaction of $96,753.44. Following the sale, the director owned...
MarketBeat·1mo ago
electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?
electroCore (ECOR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·1mo ago
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?
Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks·1mo ago
Analysts Offer Predictions for electroCore FY2030 Earnings
electroCore, Inc. (NASDAQ:ECOR - Free Report) - Equities researchers at HC Wainwright lifted their FY2030 earnings per share estimates for shares of electroCore in a research note issued to investors on Friday, March 20th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post...
MarketBeat·2mo ago
electroCore (NASDAQ:ECOR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
electroCore (NASDAQ:ECOR - Get Free Report) issued its earnings results on Thursday. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.35) by $0.01. The firm had revenue of $9.24 million for the quarter, compared to analyst estimates of $9.09...
MarketBeat·2mo ago
electroCore (ECOR) Q4 2025 Earnings Transcript
@media (max-width: 768px) {
.image-container {
width: 100% !important;
float: none !important;
margin: 0 0 1rem 0 !important;
}
}
Image source: The Mo...
Nasdaq News: Markets·2mo ago
electroCore Q4 Earnings Call Highlights
electroCore (NASDAQ:ECOR) executives highlighted record fourth-quarter revenue growth, expanding adoption within the U.S. Department of Veterans Affairs (VA) system, and accelerating sales of its Truvaga wellness product during the company's fourth-quarter and full-year 2025 earnings call. Managemen...
MarketBeat·2mo ago
<
1
2
...
>